Kahira Pharmaceuticals & Chemical Industries Company reported earnings results for the full year ended June 30, 2023. For the full year, the company reported sales was EGP 1,005.24 million compared to EGP 1,112.11 million a year ago. Net income was EGP 97.09 million compared to EGP 165.74 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
63.87 EGP | 0.00% | -9.06% | +12.94% |
1st Jan change | Capi. | |
---|---|---|
+12.94% | 19.91M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- CPCI Stock
- News Kahira Pharmaceuticals & Chemical Industries Company
- Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the Full Year Ended June 30, 2023